Amcor September 2026-End Earnings Miss on Higher Costs, View Cut

Amcor’s adjusted EPS fell 2.1% year over year to $0.95, missing the $0.96 consensus, while revenue rose 6.7% to $6.13 billion and beat estimates of $5.83 billion. Higher energy, distribution and interest costs contributed to lower margins and an $820 million free-cash outflow; net debt rose to $14.01 billion. Amcor cut six-month transition-period adjusted EPS guidance to $1.70-$1.80 from $1.80-$1.90, but reaffirmed double-digit adjusted EPS growth for calendar 2027.

Analysis

The key issue is cash conversion, not reported sales: input-cost pass-through can inflate revenue while temporarily squeezing margins and tying up working capital. That leaves AMCR exposed to a two-step test—whether cost recovery catches up in the transition period, and whether the working-capital unwind actually arrives without renewed resin volatility. With leverage already elevated, a delayed recovery could crowd out debt reduction and make the 2027 growth target less credible. The company’s claim that inflation will not affect 2027 results is a forward-looking assertion, not yet demonstrated by this quarter’s margins or cash flow.

Near term (days): the guidance cut and cash-flow deterioration are negative, but valuation and post-earnings price action are unavailable, so do not assume the shares have further downside. Over 1–3 months, focus on cost-recovery timing, segment margins, and the transition-period cash-flow bridge. Over 6–18 months, successful cash recovery and deleveraging could restore confidence; failure would increase the risk of multiple compression. PKG’s stronger results offer a possible relative-value counterpoint, but corrugated packaging is not a direct operating hedge for AMCR’s flexible/rigid portfolio. AVY’s different business mix likewise limits direct read-through. Watch for customers resisting pass-through or shifting formats; the article provides no evidence that substitution is occurring.

Key Decisions for Investors

• Keep AMCR underweight pending evidence that cost pass-through restores margins and working capital reverses. The thesis is falsified by sequential margin recovery alongside improving operating cash flow and leverage tracking toward guidance.
• Consider a small relative-value position: short AMCR / long PKG, sized as a cross-sector packaging spread rather than a matched hedge. Enter only if AMCR underperforms after the initial earnings reaction; reassess if PKG’s results weaken or AMCR demonstrates cash recovery.
• Set an alert for the transition-period report: verify cash-flow recovery against the company’s stated >$500 million expectation through calendar 2027, net-debt trajectory, and whether underlying volume growth remains positive after excluding divested businesses.
• Avoid treating the revenue beat as evidence of pricing power: separate raw-material pass-through from organic volume and margin trends in upcoming disclosures.